{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:30:59Z","timestamp":1791318659958,"version":"4.3.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.cgh.2019.05.037","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T22:44:21Z","timestamp":1559256261000},"page":"392-398.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria"],"prefix":"10.1016","volume":"18","author":[{"given":"Christopher J.","family":"Black","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8437-2925","authenticated-orcid":false,"given":"Yan","family":"Yiannakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley A.","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2019.05.037_bib1","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Mearin","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.05.037_bib2","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global prevalence of, and risk factors for, irritable bowel syndrome: a meta-analysis","volume":"10","author":"Lovell","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2019.05.037_bib3","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ajg.2012.131","article-title":"Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis","volume":"107","author":"Lovell","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.05.037_bib4","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.05.037_bib5","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2016.02.014","article-title":"Development and validation of the Rome IV diagnostic questionnaire for adults","volume":"150","author":"Palsson","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.05.037_bib6","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1053\/j.gastro.2013.08.048","article-title":"Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care","volume":"145","author":"Ford","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.05.037_bib7","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/jama.300.15.1793","article-title":"Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms?","volume":"300","author":"Ford","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2019.05.037_bib8","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41395-018-0074-z","article-title":"How the change in IBS criteria from Rome III to Rome IV impacts on clinical characteristics and key pathophysiological factors","volume":"113","author":"Aziz","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.05.037_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13189","article-title":"Rome III vs Rome IV criteria for irritable bowel syndrome: a comparison of clinical characteristics in a large cohort study","volume":"30","author":"Vork","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2019.05.037_bib10","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/jgh.13642","article-title":"Comparison of the Rome IV and Rome III criteria for IBS diagnosis: a cross-sectional survey","volume":"32","author":"Bai","year":"2017","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2019.05.037_bib11","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1177\/2050640618779923","article-title":"Post-infectious IBS: defining its clinical features and prognosis using an internet-based survey","volume":"6","author":"Card","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.cgh.2019.05.037_bib12","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2036.2003.01456.x","article-title":"The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects","volume":"17","author":"Hungin","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2019.05.037_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/gut.2010.227132","article-title":"Effect of laxatives and pharmacological therapies in chronic idipathic constipation: systematic review and meta-analysis","volume":"60","author":"Ford","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2019.05.037_bib14","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/gutjnl-2016-311835","article-title":"Comparison of efficacy of pharmacological treatments for chronic idiopathic constipation: a systematic review and network meta-analysis","volume":"66","author":"Nelson","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2019.05.037_bib15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1365-2036.2010.04328.x","article-title":"Meta-analysis: factors affecting placebo response rate in irritable bowel syndrome","volume":"32","author":"Ford","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2019.05.037_bib16","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1053\/j.gastro.2018.08.021","article-title":"Efficacy of secretagogues in patients with irritable bowel syndrome with constipation: systematic review and network meta-analysis","volume":"155","author":"Black","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.05.037_bib17","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2016.08.003","article-title":"Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant irritable bowel syndrome","volume":"151","author":"Lembo","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.05.037_bib18","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/ajg.2012.254","article-title":"Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety","volume":"107","author":"Chey","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.05.037_bib19","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/ajg.2017.41","article-title":"Tenapanor treatment of patients with constipation-predominant irritable bowel syndrome: a phase 2, randomized, placebo-controlled efficacy and safety trial","volume":"112","author":"Chey","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.05.037_bib20","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41395-018-0026-7","article-title":"Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials","volume":"113","author":"Brenner","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.05.037_bib21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa1505180","article-title":"Eluxadoline for irritable bowel syndrome with diarrhea","volume":"374","author":"Lembo","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2019.05.037_bib22","series-title":"Rome III: the functional gastrointestinal disorders","first-page":"835","article-title":"Development and validation of the Rome III diagnostic questionnaire","author":"Whitehead","year":"2006"},{"key":"10.1016\/j.cgh.2019.05.037_bib23","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2016.02.014","article-title":"Rome IV diagnostic questionnaires and tables for investigators and clinicians","volume":"150","author":"Palsson","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.05.037_bib24","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.05.037_bib25","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Mearin","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.05.037_bib26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","article-title":"The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress","volume":"11","author":"Francis","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2019.05.037_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.cgh.2019.05.037_bib28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00006842-200203000-00008","article-title":"The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms","volume":"64","author":"Kroenke","year":"2002","journal-title":"Psychosom Med"},{"key":"10.1016\/j.cgh.2019.05.037_bib29","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","article-title":"Validation and utility of a\u00a0self-report version of PRIME-MD: the PHQ primary care study\u2014Primary Care Evaluation of Mental Disorders: Patient Health Questionnaire","volume":"282","author":"Spitzer","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2019.05.037_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2307\/2136404","article-title":"A\u00a0global measure of perceived stress","volume":"24","author":"Cohen","year":"1983","journal-title":"J\u00a0Health Soc Behav"},{"key":"10.1016\/j.cgh.2019.05.037_bib31","series-title":"The social psychology of health","first-page":"31","article-title":"Perceived stress in a probability sample in the United States","author":"Cohen","year":"1988"},{"key":"10.1016\/j.cgh.2019.05.037_bib32","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.cgh.2006.09.027","article-title":"The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life","volume":"4","author":"Graff","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2019.05.037_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2036.2004.02007.x","article-title":"The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale","volume":"20","author":"Labus","year":"2004","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356519305877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356519305877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:30:18Z","timestamp":1761543018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356519305877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1542356519305877"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2019.05.037","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2019.05.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the AGA Institute","name":"copyright","label":"Copyright"}]}}